Seeking Alpha

  Akebia Therapeutics, Inc. (AKBA) - NASDAQ

  • Don Dion | Send Message 18 Mar

    IPO Could Be Too Little, Too Early For Akebia Therapeutics $AKBA
      AKBA vs. ETF Alternatives
      Company Description
      Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States